eu dpp-4 inhibitors market

EU DPP-4 inhibitors Market, by Drug Class (Januvia, Onglyza/Kombiglyze, Tradjenta, Nesina, Galvus, and other brands) Growth, Trends and Forecast, 2019-2028

  • Published Date: 2022-12-26
  • Report ID: 138285
  • Pages: 200
  • Format: prudent report format

Report Overview

The EU DPP-4 inhibitors market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 4.9% during the forecast period

DPP-4 inhibitors are important oral antidiabetic agents that are placed as second-line therapy after metformin failure as insulin tropic agents that have no intrinsic hypoglycemia risk and are body weight neutral. Under hyperglycemic conditions they additionally inhibit glucagon secretion



 

Market Drivers

The market is directly proportional to the growing type 2 diabetic population. In most of the cases, DPP-4 are the second line of drugs prescribed for type 2 patients. Over the years, the European diabetic population increased tremendously, and type 2 population accounts for almost 90% of the diabetic population. The growth in diabetic population is due to it being a lifestyle disease


1. EU DPP-4 inhibitors Market Overview
A. Market Size
2. EU DPP-4 inhibitors Market Growth Drivers
I. Growing type 2 diabetic population
II. The European diabetic population increased tremendously
3. EU DPP-4 inhibitors Market Segmentation.
A. By Drug Class
I. Januvia
II. Onglyza
III. Tradjenta
IV. Vipidia/Nesina
V. Galvus
VI. Others
4. EU DPP-4 inhibitors Market Major Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. Merck Company overview, Product & Services, Strategies & Financials
B. Astra Zeneca Company overview, Product & Services, Strategies & Financials
C. Eli Lilly Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Market Opportunities and Future Trends
A. Market Opportunities
B. Future Trends
10. Conclusion
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.